V. Bhuvarahamurthy

430 total citations
20 papers, 358 citations indexed

About

V. Bhuvarahamurthy is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, V. Bhuvarahamurthy has authored 20 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in V. Bhuvarahamurthy's work include Cancer-related Molecular Pathways (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). V. Bhuvarahamurthy is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Carbohydrate Chemistry and Synthesis (3 papers). V. Bhuvarahamurthy collaborates with scholars based in India, Germany and United States. V. Bhuvarahamurthy's co-authors include S. Govindasamy, N. Balasubramanian, K Kannan, G. Shanmugam, Nobuo Tsuchida, Arasambattu Kannan Munirajan, Stefan A. Loening, Klaus Jung, Glen Kristiansen and Dietmar Schnorr and has published in prestigious journals such as PLoS ONE, Gynecologic Oncology and Cells.

In The Last Decade

V. Bhuvarahamurthy

19 papers receiving 328 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
V. Bhuvarahamurthy India 12 183 83 62 37 35 20 358
Maria Paola Smacchia Italy 6 164 0.9× 73 0.9× 40 0.6× 28 0.8× 31 0.9× 12 446
Susumu Ohshima Japan 13 157 0.9× 67 0.8× 51 0.8× 29 0.8× 22 0.6× 32 428
Jana Y. Wo Hong Kong 7 246 1.3× 48 0.6× 101 1.6× 60 1.6× 23 0.7× 8 401
Masami Komiya Japan 12 164 0.9× 85 1.0× 93 1.5× 29 0.8× 26 0.7× 27 336
Sabrieh Amini Iran 11 177 1.0× 119 1.4× 57 0.9× 26 0.7× 56 1.6× 28 403
Luis A. Espinoza United States 11 269 1.5× 163 2.0× 100 1.6× 25 0.7× 61 1.7× 19 461
Soo Im Choi South Korea 12 203 1.1× 68 0.8× 79 1.3× 21 0.6× 45 1.3× 24 376
Xiaoying Zhao China 13 245 1.3× 86 1.0× 70 1.1× 29 0.8× 26 0.7× 35 501
Krista LaPerle United States 7 191 1.0× 124 1.5× 41 0.7× 26 0.7× 35 1.0× 8 499

Countries citing papers authored by V. Bhuvarahamurthy

Since Specialization
Citations

This map shows the geographic impact of V. Bhuvarahamurthy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Bhuvarahamurthy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Bhuvarahamurthy more than expected).

Fields of papers citing papers by V. Bhuvarahamurthy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Bhuvarahamurthy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Bhuvarahamurthy. The network helps show where V. Bhuvarahamurthy may publish in the future.

Co-authorship network of co-authors of V. Bhuvarahamurthy

This figure shows the co-authorship network connecting the top 25 collaborators of V. Bhuvarahamurthy. A scholar is included among the top collaborators of V. Bhuvarahamurthy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Bhuvarahamurthy. V. Bhuvarahamurthy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Malathi, S., Nandakumar Venkatesan, Rajesh Kumar Dhanaraj, et al.. (2023). Epidermal growth factor receptor targeted doxorubicin and vitexin loaded niosomes for enhanced breast cancer therapy. Materials Advances. 4(21). 5224–5237. 8 indexed citations
4.
5.
Ramesh, Janani, et al.. (2020). Characterisation of ACP5 missense mutations encoding tartrate-resistant acid phosphatase associated with spondyloenchondrodysplasia. PLoS ONE. 15(3). e0230052–e0230052. 7 indexed citations
6.
Bhuvarahamurthy, V., Glen Kristiansen, Manfred Johannsen, et al.. (2006). In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncology Reports. 15(5). 1379–84. 45 indexed citations
7.
Bhuvarahamurthy, V., Joerg Schroeder, Glen Kristiansen, et al.. (2005). Differential gene expression of urokinase-type plasminogen activator and its receptor in human renal cell carcinoma. Oncology Reports. 14(3). 777–82. 13 indexed citations
8.
Bhuvarahamurthy, V., Joerg Schroeder, Carsten Denkert, et al.. (2004). In situ gene expression of urokinase-type plasminogen activator and its receptor in transitional cell carcinoma of the human bladder. Oncology Reports. 12(4). 909–13. 14 indexed citations
9.
Kannan, K, et al.. (2000). FHIT Gene mutations and single nucleotide polymorphism in Indian oral and cervical squamous cell carcinomas. Oral Oncology. 36(2). 189–193. 13 indexed citations
10.
Kannan, K, Arasambattu Kannan Munirajan, Janakiraman Krishnamurthy, et al.. (2000). The p16INK4alpha/p19ARF gene mutations are infrequent and are mutually exclusive to p53 mutations in Indian oral squamous cell carcinomas.. International Journal of Oncology. 16(3). 585–90. 14 indexed citations
11.
Kannan, K, Arasambattu Kannan Munirajan, Jairam Krishnamurthy, et al.. (1999). Low incidence of p53 mutations in betel quid and tobacco chewing-associated oral squamous carcinoma from India.. International Journal of Oncology. 15(6). 1133–6. 27 indexed citations
12.
Munirajan, Arasambattu Kannan, K Kannan, V. Bhuvarahamurthy, et al.. (1998). The Status of Human Papillomavirus and Tumor Suppressor Genesp53andp16in Carcinomas of Uterine Cervix from India. Gynecologic Oncology. 69(3). 205–209. 31 indexed citations
13.
Bhuvarahamurthy, V. & S. Govindasamy. (1996). Purification and Characterization of Hexosaminidase from Human Uterine Cervical Carcinoma. Gynecologic Oncology. 60(2). 188–196. 7 indexed citations
14.
Bhuvarahamurthy, V., N. Balasubramanian, & S. Govindasamy. (1996). Effect of radiotherapy and chemoradiotherapy on circulating antioxidant system of human uterine cervical carcinoma. Molecular and Cellular Biochemistry. 158(1). 17–23. 69 indexed citations
15.
Bhuvarahamurthy, V. & S. Govindasamy. (1995). Extracellular matrix components and proteolytic enzymes in uterine cervical carcinoma. Molecular and Cellular Biochemistry. 144(1). 35–43. 7 indexed citations
16.
Bhuvarahamurthy, V., N. Balasubramanian, Sekar Vijayakumar, & S. Govindasamy. (1995). Effect of radiation on serum glycoproteins and glycosidases in patients with cervical carcinoma. International Journal of Gynecology & Obstetrics. 48(1). 49–54. 13 indexed citations
17.
Balasubramaniyan, Natarajan, et al.. (1994). Involvement of plasma copper, zinc and cadmium in human carcinoma of uterine cervix. Medical Oncology. 11(3-4). 147–148. 7 indexed citations
18.
Bhuvarahamurthy, V., N. Balasubramanian, S. Subramanian, & S. Govindasamy. (1992). Studies on variations of glycoproteins and lysosomal hydrolases in human uterine cervical carcinoma.. PubMed. 28(1). 105–11. 3 indexed citations
19.
Bhuvarahamurthy, V., et al.. (1955). Occurrence of alkaline pyrophosphatase in vegetable tissues. Biochemical Journal. 60(2). 224–225. 34 indexed citations
20.
Bhuvarahamurthy, V., et al.. (1955). Potato pyrophosphatases. Biochemical Journal. 60(2). 215–223. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026